Great Basin Toxigenic C. difficile Direct Test (CDF2)
Nov 2023
124d
Vela Operations USA
1
Total
1
Cleared
0
Denied
Vela Operations USA — FDA 510(k) Submissions
Vela Operations USA has submitted 1 FDA 510(k) premarket notifications since 2023, of which 1 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include C. Difficile Toxin Gene Amplification Assay . Use the specialty filter in the sidebar to narrow results.
1 devices